fbpx Skip to main content
 

Search

Janssen Search

Search results

701 SEARCH RESULTS FOR

research-development

Not finding what you're looking for? Visit Janssen in your country.
PAGE 8 OF 71

Pages

JAMES MERSON, Ph.D. GLOBAL HEAD INFECTIOUS DISEASES James Merson, Ph.D., is the Global Therapeutic Area Head for Infectious Diseases at Janssen Research & Development, L.L.C. He is a member of the Senior R&D Leadership Team, leading the global ...

As the Strategy and Operations Support Leader for the Disease Interception Accelerator (DIA), Dave Yazujian drives the development and execution of the DIA strategy, ensuring operational efficiency and effectiveness and integrating input from Janssen ...

DAN CUA, PH.D. VICE PRESIDENT IL-23 PATHWAY AREA LEADER Dan Cua, Ph.D. is Vice President, IL-23 Pathway Area Leader for the Immunology Therapeutic Area at Janssen Research and Development, LLC. In this role, Dan oversees the design and implementation of ...

Global CEO Initiative on Alzheimer's Disease As part of a worldwide effort to find better ways to treat the disease, Janssen joined the Global CEO Initiative on Alzheimer’s Disease (CEOi), a collaboration of public and private partnerships with ...

DAVID M. LEE, M.D., Ph.D. GLOBAL THERAPEUTIC AREA HEAD IMMUNOLOGY David M. Lee, M.D., Ph.D., is Global Immunology Therapeutic Area Head for the Janssen Pharmaceutical Companies of Johnson & Johnson where he leads a team focused on end-to-end pipeline ...

With the American Society of Clinical Oncology (ASCO) moving to a virtual platform for its 2020 Annual Meeting, Janssen Oncology remains determined in our efforts to champion science for patients. Thank you for visiting to check out our news from ASCO2020 ...

The Dr. Paul Janssen Award for Biomedical Research The Dr. Paul Janssen Award for Biomedical Research aims to extend the legacy of Dr. Paul Janssen by honoring the work of an active scientist in academia, industry or a scientific institute. Dr. Paul, as ...

We invite you to partner with us. We recognize the importance of building strong working partnerships that can advance the quality of healthcare globally, respect and protect the environment, and support our sense of responsibility to local communities. ...

Patience, Perseverance and Partnership   We envision a world where cancer is a preventable, chronic or curable disease. To get there, we’re focused on developing solutions that prolong and improve patient lives. In this post, we’re proud to introduce you ...

JOHN C. REED, M.D., PH.D. EXECUTIVE VICE PRESIDENT PHARMACEUTICALS, R&D JOHNSON & JOHNSON As Executive Vice President, Pharmaceuticals, R&D and Johnson & Johnson (J&J) Executive Committee member, John’s mission is to focus the best ...

701 SEARCH RESULTS FOR

research-development

Not finding what you're looking for? Visit Janssen in your country.
PAGE 8 OF 71

Pages